Metabolic research
Eloralintide
Investigational amylin-receptor medicine in clinical trials. Not FDA-approved.
- Type
- Investigational medicine
- Research area
- Metabolic research
- Research stage
- Clinical trials
- FDA status
- Not an FDA-approved medicine
About Eloralintide
Investigational amylin-receptor medicine in clinical trials. Not FDA-approved.
Where the research stands
Most published work on this compound comes from laboratory, animal or early human studies. Results in those settings don't always carry over to people, and long-term safety data are limited.
Read the studies
Educational information only; not medical advice. Talk to a licensed doctor before using any compound.
Related compounds
CagriSemaCagriSema
Investigational combination of cagrilintide and semaglutide in clinical trials. Not FDA-approved.
TesofensineTesofensine
Studied in clinical research; not approved in the United States.
RetatrutideRetatrutide
Investigational triple-agonist medicine in clinical trials. Not FDA-approved.